182 related articles for article (PubMed ID: 12621103)
21. Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease.
Gong F; Zhang Y; Xie C; Zhu W; Wang W; Fu S; Shen H
Pediatr Res; 2012 Jun; 71(6):720-4. PubMed ID: 22337222
[TBL] [Abstract][Full Text] [Related]
22. Clinical value of echocardiography combined with serum Cav-1, NFATc1, and PAI-1 in the diagnosis of Kawasaki disease complicated with coronary artery lesions.
Zhang Y; Liu J
Heart Vessels; 2024 Jan; 39(1):18-24. PubMed ID: 37758852
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease.
Oseroff A; Krishnamurti C; Hassett A; Tang D; Alving B
J Lab Clin Med; 1989 Jan; 113(1):88-93. PubMed ID: 2783330
[TBL] [Abstract][Full Text] [Related]
24. ITPKC gene SNP rs28493229 and Kawasaki disease in Taiwanese children.
Chi H; Huang FY; Chen MR; Chiu NC; Lee HC; Lin SP; Chen WF; Lin CL; Chan HW; Liu HF; Huang LM; Lee YJ
Hum Mol Genet; 2010 Mar; 19(6):1147-51. PubMed ID: 20045869
[TBL] [Abstract][Full Text] [Related]
25. Relationship between adipokines and coronary artery aneurysm in children with Kawasaki disease.
Liu R; He B; Gao F; Liu Q; Yi Q
Transl Res; 2012 Aug; 160(2):131-6. PubMed ID: 22683371
[TBL] [Abstract][Full Text] [Related]
26. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease.
Kariyazono H; Ohno T; Khajoee V; Ihara K; Kusuhara K; Kinukawa N; Mizuno Y; Hara T
Pediatr Res; 2004 Dec; 56(6):953-9. PubMed ID: 15470196
[TBL] [Abstract][Full Text] [Related]
27. Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease.
Yu X; Hirono KI; Ichida F; Uese K; Rui C; Watanabe S; Watanabe K; Hashimoto I; Kumada T; Okada E; Terai M; Suzuki A; Miyawaki T
Pediatr Res; 2004 Apr; 55(4):688-94. PubMed ID: 14764920
[TBL] [Abstract][Full Text] [Related]
28. Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).
Harbeck N; Kates RE; Look MP; Meijer-Van Gelder ME; Klijn JG; Krüger A; Kiechle M; Jänicke F; Schmitt M; Foekens JA
Cancer Res; 2002 Aug; 62(16):4617-22. PubMed ID: 12183417
[TBL] [Abstract][Full Text] [Related]
29. Elastolytic matrix metalloproteinases and coronary outcome in children with Kawasaki disease.
Lau AC; Rosenberg H; Duong TT; McCrindle BW; Yeung RS
Pediatr Res; 2007 Jun; 61(6):710-5. PubMed ID: 17426658
[TBL] [Abstract][Full Text] [Related]
30. Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.
Miura M; Ohki H; Tsuchihashi T; Yamagishi H; Katada Y; Yamada K; Yamashita Y; Sugaya A; Komiyama O; Shiro H
Arch Dis Child; 2004 Aug; 89(8):776-80. PubMed ID: 15269082
[TBL] [Abstract][Full Text] [Related]
31. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F
J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
[TBL] [Abstract][Full Text] [Related]
32. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
33. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
34. The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer.
Manders P; Tjan-Heijnen VC; Span PN; Grebenchtchikov N; Geurts-Moespot AJ; van Tienoven DT; Beex LV; Sweep FC
Thromb Haemost; 2004 Mar; 91(3):514-21. PubMed ID: 14983227
[TBL] [Abstract][Full Text] [Related]
35. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
[TBL] [Abstract][Full Text] [Related]
36. Single-Cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease.
Chen Y; Yang M; Zhang M; Wang H; Zheng Y; Sun R; Li X
Arterioscler Thromb Vasc Biol; 2024 Apr; 44(4):866-882. PubMed ID: 38357816
[TBL] [Abstract][Full Text] [Related]
37. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
[TBL] [Abstract][Full Text] [Related]
38. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
Buduneli N; Buduneli E; Ciotanar S; Atilla G; Lappin D; Kinane D
J Clin Periodontol; 2004 Jul; 31(7):556-61. PubMed ID: 15191592
[TBL] [Abstract][Full Text] [Related]
39. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
Xiao W; Tong WL; Ma DD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
[TBL] [Abstract][Full Text] [Related]
40. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
